Moshe Levi, MD, is Interim Dean for Research at Georgetown University Medical Center and is a professor in the Department of Biochemistry and Molecular & Cellular Biology.

Levi completed undergraduate training in chemical engineering at Northwestern University and received an MS in chemical engineering at Stanford University. He earned his MD from Albert Einstein College of Medicine and completed his internal medicine internship and residency at Cornell University, Memorial Sloan Kettering Hospital and NorthShore University Hospital . He completed a nephrology clinical and research fellowship at the University of Colorado Health Sciences Center.

Funded by numerous NIH grants including three R01s (one he obtained since joining GUMC in addition to a significant supplement), Levi’s research involves renal, hepatic and cardiovascular complications of obesity, diabetes and aging; regulation of mineral metabolism; and applying new label free techniques for imaging lipids, inflammation, oxidative stress, metabolism, and fibrosis. He has co-authored 200 manuscripts and nearly 40 book chapters, and has mentored more than 36 MD or PhD research trainees. Moshe also serves as the Chair of the Board of American Physician Scientist Association (APSA), an organization of MD/PhD students and scientists, and president of the Kern Lipid Conference Board.

Prior to joining Georgetown, from 2002 to 2017, Levi was professor of medicine, physiology and biophysics, and bioengineering at the University of Colorado Health Sciences Center, where from 2005 to 2011 he served as vice chair of research for the Department of Medicine with over 400 faculty members. He also served on the executive committee of the NIH CCTSI Microscopy Technology Core Lab and the Clinical and Translational Imaging Research Center, and as a member of the Center for Fibrosis Research and Translation. Earlier in his career, Levi practiced medicine at the Department of Veterans Affairs Medical Center in Dallas, where he was chief of the nephrology section, and at University of Texas Southwestern Medical Center from 1984 to 2002, where he was professor of internal medicine.

Levi has served on numerous study sections and associated grant review committees.

In 2013, he was appointed a member of the Board of Scientific Counselors for the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases. He recently concluded his service as its chair.

Levi continues to serve as an NIH National Advisory Committee member for the Laboratory for Fluorescence Dynamics at the University of California Irvine and the O’Brien Center in Kidney Research at UT Southwestern Medical School.

Levi is a fellow of the American Heart Association, the American Society of Nephrology, and the American Physiological Society, and is a member of numerous professional associations where he has served in committees and leadership roles. Memberships include the American Physiological Society, the American Society of Nephrology, National Kidney Foundation, International Society of Nephrology, American Heart Association, American Diabetes Association, Juvenile Diabetes Research Foundation, the American Association for the Advancement of Science, Biophysical Society, American Society for Biochemistry and Molecular Biology, American Society for Cell Biology, and the American Association for the Study of Liver Disease.

He serves on the editorial boards of the Journal of Biological Chemistry and Diabetes.

Levi is a married to a physician and is the father of two young adult children.